カテゴリー： QYResearch, 世界, 医療/バイオ

世界のプラスミドDNA製造サービス市場インサイト及び予測（研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他）

◆英語タイトル：Global Plasmid DNA Manufacturing Services Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09276 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：116 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、プラスミドDNA製造サービスのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプラスミドDNA製造サービスの世界市場のxxx％を占める「研究用プラスミド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療産業」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
プラスミドDNA製造サービスの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプラスミドDNA製造サービス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

プラスミドDNA製造サービスのグローバル主要企業には、Vigene Biosciences、Aldevron、Creative Biogene、Thermo Fisher Scientific Inc.、Kaneka Eurogentec SA、AGC Biologics、Andelyn Biosciences、Biomay、VGXI, Inc.、VectorBuilder、Xpress Biologics、Biovian、WuXi Advanced Therapies、Catalent, Inc、Charles River Laboratories、Esco Aster Pte. Ltd、Waisman、Boehringer Ingelheim Biopharmaceuticals GmbHなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

プラスミドDNA製造サービス市場は、種類と用途によって区分されます。世界のプラスミドDNA製造サービス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他

【用途別セグメント】
医療産業、生物産業、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- プラスミドDNA製造サービス製品概要
- 種類別市場（研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他）
- 用途別市場（医療産業、生物産業、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のプラスミドDNA製造サービス販売量予測2017-2028
- 世界のプラスミドDNA製造サービス売上予測2017-2028
- プラスミドDNA製造サービスの地域別販売量
- プラスミドDNA製造サービスの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別プラスミドDNA製造サービス販売量
- 主要メーカー別プラスミドDNA製造サービス売上
- 主要メーカー別プラスミドDNA製造サービス価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他）
- プラスミドDNA製造サービスの種類別販売量
- プラスミドDNA製造サービスの種類別売上
- プラスミドDNA製造サービスの種類別価格
・用途別市場規模（医療産業、生物産業、その他）
- プラスミドDNA製造サービスの用途別販売量
- プラスミドDNA製造サービスの用途別売上
- プラスミドDNA製造サービスの用途別価格
・北米市場
- 北米のプラスミドDNA製造サービス市場規模（種類別、用途別）
- 主要国別のプラスミドDNA製造サービス市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのプラスミドDNA製造サービス市場規模（種類別、用途別）
- 主要国別のプラスミドDNA製造サービス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のプラスミドDNA製造サービス市場規模（種類別、用途別）
- 主要国別のプラスミドDNA製造サービス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のプラスミドDNA製造サービス市場規模（種類別、用途別）
- 主要国別のプラスミドDNA製造サービス市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのプラスミドDNA製造サービス市場規模（種類別、用途別）
- 主要国別のプラスミドDNA製造サービス市場規模（トルコ、サウジアラビア）
・企業情報
Vigene Biosciences、Aldevron、Creative Biogene、Thermo Fisher Scientific Inc.、Kaneka Eurogentec SA、AGC Biologics、Andelyn Biosciences、Biomay、VGXI, Inc.、VectorBuilder、Xpress Biologics、Biovian、WuXi Advanced Therapies、Catalent, Inc、Charles River Laboratories、Esco Aster Pte. Ltd、Waisman、Boehringer Ingelheim Biopharmaceuticals GmbH
・産業チェーン及び販売チャネル分析
- プラスミドDNA製造サービスの産業チェーン分析
- プラスミドDNA製造サービスの原材料
- プラスミドDNA製造サービスの生産プロセス
- プラスミドDNA製造サービスの販売及びマーケティング
- プラスミドDNA製造サービスの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- プラスミドDNA製造サービスの産業動向
- プラスミドDNA製造サービスのマーケットドライバー
- プラスミドDNA製造サービスの課題
- プラスミドDNA製造サービスの阻害要因
・主な調査結果

Market Analysis and Insights: Global Plasmid DNA Manufacturing Services Market
The global Plasmid DNA Manufacturing Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Research-Grade Plasmids accounting for % of the Plasmid DNA Manufacturing Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Industry segment is altered to an % CAGR throughout this forecast period.
China Plasmid DNA Manufacturing Services market size is valued at US$ million in 2021, while the North America and Europe Plasmid DNA Manufacturing Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Plasmid DNA Manufacturing Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasmid DNA Manufacturing Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasmid DNA Manufacturing Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasmid DNA Manufacturing Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasmid DNA Manufacturing Services market.
Global Plasmid DNA Manufacturing Services Scope and Market Size
Plasmid DNA Manufacturing Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Plasmid DNA Manufacturing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Research-Grade Plasmids
High Quality (HQ) / GMP-Ready™ Plasmids
CGMP Plasmid
Others
Segment by Application
Medical Industry
Biological Industry
Others
By Company
Vigene Biosciences
Aldevron
Creative Biogene
Thermo Fisher Scientific Inc.
Kaneka Eurogentec SA
AGC Biologics
Andelyn Biosciences
Biomay
VGXI, Inc.
VectorBuilder
Xpress Biologics
Biovian
WuXi Advanced Therapies
Catalent, Inc
Charles River Laboratories
Esco Aster Pte. Ltd
Waisman
Boehringer Ingelheim Biopharmaceuticals GmbH
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA Manufacturing Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Research-Grade Plasmids
1.2.3 High Quality (HQ) / GMP-Ready™ Plasmids
1.2.4 CGMP Plasmid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasmid DNA Manufacturing Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Industry
1.3.3 Biological Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA Manufacturing Services Market Perspective (2017-2028)
2.2 Plasmid DNA Manufacturing Services Growth Trends by Region
2.2.1 Plasmid DNA Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmid DNA Manufacturing Services Historic Market Size by Region (2017-2022)
2.2.3 Plasmid DNA Manufacturing Services Forecasted Market Size by Region (2023-2028)
2.3 Plasmid DNA Manufacturing Services Market Dynamics
2.3.1 Plasmid DNA Manufacturing Services Industry Trends
2.3.2 Plasmid DNA Manufacturing Services Market Drivers
2.3.3 Plasmid DNA Manufacturing Services Market Challenges
2.3.4 Plasmid DNA Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA Manufacturing Services Players by Revenue
3.1.1 Global Top Plasmid DNA Manufacturing Services Players by Revenue (2017-2022)
3.1.2 Global Plasmid DNA Manufacturing Services Revenue Market Share by Players (2017-2022)
3.2 Global Plasmid DNA Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA Manufacturing Services Revenue
3.4 Global Plasmid DNA Manufacturing Services Market Concentration Ratio
3.4.1 Global Plasmid DNA Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA Manufacturing Services Revenue in 2021
3.5 Plasmid DNA Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Plasmid DNA Manufacturing Services Product Solution and Service
3.7 Date of Enter into Plasmid DNA Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA Manufacturing Services Breakdown Data by Type
4.1 Global Plasmid DNA Manufacturing Services Historic Market Size by Type (2017-2022)
4.2 Global Plasmid DNA Manufacturing Services Forecasted Market Size by Type (2023-2028)
5 Plasmid DNA Manufacturing Services Breakdown Data by Application
5.1 Global Plasmid DNA Manufacturing Services Historic Market Size by Application (2017-2022)
5.2 Global Plasmid DNA Manufacturing Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmid DNA Manufacturing Services Market Size (2017-2028)
6.2 North America Plasmid DNA Manufacturing Services Market Size by Type
6.2.1 North America Plasmid DNA Manufacturing Services Market Size by Type (2017-2022)
6.2.2 North America Plasmid DNA Manufacturing Services Market Size by Type (2023-2028)
6.2.3 North America Plasmid DNA Manufacturing Services Market Share by Type (2017-2028)
6.3 North America Plasmid DNA Manufacturing Services Market Size by Application
6.3.1 North America Plasmid DNA Manufacturing Services Market Size by Application (2017-2022)
6.3.2 North America Plasmid DNA Manufacturing Services Market Size by Application (2023-2028)
6.3.3 North America Plasmid DNA Manufacturing Services Market Share by Application (2017-2028)
6.4 North America Plasmid DNA Manufacturing Services Market Size by Country
6.4.1 North America Plasmid DNA Manufacturing Services Market Size by Country (2017-2022)
6.4.2 North America Plasmid DNA Manufacturing Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasmid DNA Manufacturing Services Market Size (2017-2028)
7.2 Europe Plasmid DNA Manufacturing Services Market Size by Type
7.2.1 Europe Plasmid DNA Manufacturing Services Market Size by Type (2017-2022)
7.2.2 Europe Plasmid DNA Manufacturing Services Market Size by Type (2023-2028)
7.2.3 Europe Plasmid DNA Manufacturing Services Market Share by Type (2017-2028)
7.3 Europe Plasmid DNA Manufacturing Services Market Size by Application
7.3.1 Europe Plasmid DNA Manufacturing Services Market Size by Application (2017-2022)
7.3.2 Europe Plasmid DNA Manufacturing Services Market Size by Application (2023-2028)
7.3.3 Europe Plasmid DNA Manufacturing Services Market Share by Application (2017-2028)
7.4 Europe Plasmid DNA Manufacturing Services Market Size by Country
7.4.1 Europe Plasmid DNA Manufacturing Services Market Size by Country (2017-2022)
7.4.2 Europe Plasmid DNA Manufacturing Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA Manufacturing Services Market Size (2017-2028)
8.2 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Type
8.2.1 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmid DNA Manufacturing Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Application
8.3.1 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmid DNA Manufacturing Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Region
8.4.1 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmid DNA Manufacturing Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid DNA Manufacturing Services Market Size (2017-2028)
9.2 Latin America Plasmid DNA Manufacturing Services Market Size by Type
9.2.1 Latin America Plasmid DNA Manufacturing Services Market Size by Type (2017-2022)
9.2.2 Latin America Plasmid DNA Manufacturing Services Market Size by Type (2023-2028)
9.2.3 Latin America Plasmid DNA Manufacturing Services Market Share by Type (2017-2028)
9.3 Latin America Plasmid DNA Manufacturing Services Market Size by Application
9.3.1 Latin America Plasmid DNA Manufacturing Services Market Size by Application (2017-2022)
9.3.2 Latin America Plasmid DNA Manufacturing Services Market Size by Application (2023-2028)
9.3.3 Latin America Plasmid DNA Manufacturing Services Market Share by Application (2017-2028)
9.4 Latin America Plasmid DNA Manufacturing Services Market Size by Country
9.4.1 Latin America Plasmid DNA Manufacturing Services Market Size by Country (2017-2022)
9.4.2 Latin America Plasmid DNA Manufacturing Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA Manufacturing Services Market Size (2017-2028)
10.2 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Type
10.2.1 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmid DNA Manufacturing Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Application
10.3.1 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmid DNA Manufacturing Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Country
10.4.1 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmid DNA Manufacturing Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vigene Biosciences
11.1.1 Vigene Biosciences Company Details
11.1.2 Vigene Biosciences Business Overview
11.1.3 Vigene Biosciences Plasmid DNA Manufacturing Services Introduction
11.1.4 Vigene Biosciences Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.1.5 Vigene Biosciences Recent Developments
11.2 Aldevron
11.2.1 Aldevron Company Details
11.2.2 Aldevron Business Overview
11.2.3 Aldevron Plasmid DNA Manufacturing Services Introduction
11.2.4 Aldevron Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.2.5 Aldevron Recent Developments
11.3 Creative Biogene
11.3.1 Creative Biogene Company Details
11.3.2 Creative Biogene Business Overview
11.3.3 Creative Biogene Plasmid DNA Manufacturing Services Introduction
11.3.4 Creative Biogene Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.3.5 Creative Biogene Recent Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.4.5 Thermo Fisher Scientific Inc. Recent Developments
11.5 Kaneka Eurogentec SA
11.5.1 Kaneka Eurogentec SA Company Details
11.5.2 Kaneka Eurogentec SA Business Overview
11.5.3 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Introduction
11.5.4 Kaneka Eurogentec SA Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.5.5 Kaneka Eurogentec SA Recent Developments
11.6 AGC Biologics
11.6.1 AGC Biologics Company Details
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Plasmid DNA Manufacturing Services Introduction
11.6.4 AGC Biologics Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.6.5 AGC Biologics Recent Developments
11.7 Andelyn Biosciences
11.7.1 Andelyn Biosciences Company Details
11.7.2 Andelyn Biosciences Business Overview
11.7.3 Andelyn Biosciences Plasmid DNA Manufacturing Services Introduction
11.7.4 Andelyn Biosciences Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.7.5 Andelyn Biosciences Recent Developments
11.8 Biomay
11.8.1 Biomay Company Details
11.8.2 Biomay Business Overview
11.8.3 Biomay Plasmid DNA Manufacturing Services Introduction
11.8.4 Biomay Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.8.5 Biomay Recent Developments
11.9 VGXI, Inc.
11.9.1 VGXI, Inc. Company Details
11.9.2 VGXI, Inc. Business Overview
11.9.3 VGXI, Inc. Plasmid DNA Manufacturing Services Introduction
11.9.4 VGXI, Inc. Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.9.5 VGXI, Inc. Recent Developments
11.10 VectorBuilder
11.10.1 VectorBuilder Company Details
11.10.2 VectorBuilder Business Overview
11.10.3 VectorBuilder Plasmid DNA Manufacturing Services Introduction
11.10.4 VectorBuilder Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.10.5 VectorBuilder Recent Developments
11.11 Xpress Biologics
11.11.1 Xpress Biologics Company Details
11.11.2 Xpress Biologics Business Overview
11.11.3 Xpress Biologics Plasmid DNA Manufacturing Services Introduction
11.11.4 Xpress Biologics Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.11.5 Xpress Biologics Recent Developments
11.12 Biovian
11.12.1 Biovian Company Details
11.12.2 Biovian Business Overview
11.12.3 Biovian Plasmid DNA Manufacturing Services Introduction
11.12.4 Biovian Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.12.5 Biovian Recent Developments
11.13 WuXi Advanced Therapies
11.13.1 WuXi Advanced Therapies Company Details
11.13.2 WuXi Advanced Therapies Business Overview
11.13.3 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Introduction
11.13.4 WuXi Advanced Therapies Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.13.5 WuXi Advanced Therapies Recent Developments
11.14 Catalent, Inc
11.14.1 Catalent, Inc Company Details
11.14.2 Catalent, Inc Business Overview
11.14.3 Catalent, Inc Plasmid DNA Manufacturing Services Introduction
11.14.4 Catalent, Inc Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.14.5 Catalent, Inc Recent Developments
11.15 Charles River Laboratories
11.15.1 Charles River Laboratories Company Details
11.15.2 Charles River Laboratories Business Overview
11.15.3 Charles River Laboratories Plasmid DNA Manufacturing Services Introduction
11.15.4 Charles River Laboratories Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.15.5 Charles River Laboratories Recent Developments
11.16 Esco Aster Pte. Ltd
11.16.1 Esco Aster Pte. Ltd Company Details
11.16.2 Esco Aster Pte. Ltd Business Overview
11.16.3 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Introduction
11.16.4 Esco Aster Pte. Ltd Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.16.5 Esco Aster Pte. Ltd Recent Developments
11.17 Waisman
11.17.1 Waisman Company Details
11.17.2 Waisman Business Overview
11.17.3 Waisman Plasmid DNA Manufacturing Services Introduction
11.17.4 Waisman Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.17.5 Waisman Recent Developments
11.18 Boehringer Ingelheim Biopharmaceuticals GmbH
11.18.1 Boehringer Ingelheim Biopharmaceuticals GmbH Company Details
11.18.2 Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview
11.18.3 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Introduction
11.18.4 Boehringer Ingelheim Biopharmaceuticals GmbH Revenue in Plasmid DNA Manufacturing Services Business (2017-2022)
11.18.5 Boehringer Ingelheim Biopharmaceuticals GmbH Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のプラスミドDNA製造サービス市場インサイト及び予測（研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他）(Global Plasmid DNA Manufacturing Services Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のプラスミドDNA製造サービス市場インサイト及び予測（研究用プラスミド、高品質（HQ）/GMP-Ready™プラスミド、CGMPプラスミド、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp